Red List

ACETAdicet Bio, Inc.

Healthcare · Biotechnology · micro-cap ($74M)
-50.5%
from rolling 252-day high of $17.44 set 2025-10-13 · 227d ago
Current
$8.64
Decline depth
-50.5%
Decline σ
1.7σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since tracking began

$ACET has been tracked since 2026-03-01. It was down 58.2% from its 52-week high then — now down -50.5%.

It has clawed back 4.4 percentage points off that level. It bottomed 65.0% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

ACET qualifies for the Red List on decline depth.

Decline depth
-50.5%
From rolling 252-day high of $17.44, 227d ago. Past the 40% Red List threshold.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 3/5 Watch threshold.
Decline sigma
1.7σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (4.08% per day).

The structural read

What price action says about ACET.

ACET qualifies for the Red List on decline depth — down -50.5% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.

Cross-confirmation: also showing 3/5 bearish time frames.

Earnings on file: 2026-05-13. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $6.01 23.0% of range 52W high $17.44

Sector context · Healthcare

194 other Healthcare tickers are on Broken Stocks.

88 Red List
47 Amber
59 Watch
-35.8% Median decline

Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →

Questions about ACET

What people ask.

Why is ACET on Broken Stocks?

ACET qualifies for the Red List on decline depth. It is down -50.5% from its rolling 252-day high of $17.44, set on 2025-10-13 — 227d ago.

Is ACET a falling knife?

Not by the strict technical definition. ACET is down -50.5% from its 52-week high, but that high was set 227d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. ACET is still on the Red List for decline depth, but the freshness component of a falling knife is missing.

Is ACET a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is ACET trading inside its 52-week range?

At $8.64, ACET sits 23.0% of the way from its 52-week low ($6.01) to its 52-week high ($17.44). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has ACET been declining?

The current 50.5% decline accrued over 227d, which annualizes to roughly -81.2% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does ACET compare to its sector?

There are 194 other Healthcare tickers on Broken Stocks: 88 Red, 47 Amber, 59 Watch, with 108 showing recovering structural signals. Median sector decline is -35.8% — ACET's decline is deeper than the sector median.

Does ACET's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-13) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.